Clinical Trials in Boston

Showing 10961-10980 of 17,836 trials

Mucinex® for Treatment of Filamentary Keratitis

NCT02859246

It is a pilot study aimed to determine if oral Mucinex® is effective in reducing the amount of corneal filaments and improving symptomology in subjects with filamentary keratitis.

Filamentary Keratitis

Massachusetts Eye and Ear Infirmary15 participantsStarted Sep 2016

Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

Expanded Game Squad for Neurodiverse Youth

NCT03665415

The proposed study will pilot the use of an adapted Game Squad intervention aimed at improving physical activity and other important health behaviors (nutrition, sleep hygiene, screen time habits) for children and adolescents receiving special education supports for behavioral health challenges, or who are served by the Boston Medical Center Developmental and Behavioral Pediatrics (BMC-DBP) clinic.

Physical ActivityMental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)Health Behavior+1 more

Merrimack College23 participantsStarted Nov 2018

Boston, Massachusetts, United States • Marblehead, Massachusetts, United States

COMPLETEDPhase 2< 1 mile

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma

NCT01498328

The purpose of this research study is to find out whether adding an experimental vaccine called rindopepimut (also known as CDX-110) to the commonly used drug bevacizumab can improve progression free survival (slowing the growth of tumors) of patients with relapsed EGFRvIII positive glioblastoma.

GlioblastomaSmall Cell GlioblastomaGiant Cell Glioblastoma+4 more

Celldex Therapeutics127 participantsStarted Dec 2011

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +42 more locations

Mucinex® for Treatment of Filamentary Keratitis

Expanded Game Squad for Neurodiverse Youth

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma

Find Trials by Condition in Boston

Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat

S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers

Post-Approval Prospective Study - Conventus CAGE™ PH for Use in Proximal Humerus Fracture Fixation

BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study

A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab

A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Online Obesity Treatment in Primary Care (Rhode Island, USA)

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease

A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer

Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer

Mitroflow DL Post Approval Study- North America

WallFlex Biliary Fully Covered (FC) Benign Stricture Study